Q BioMed Inc (QBIO)
0.0002
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Q BioMed Total Liabilities (Quarterly): 9.906M for Feb. 28, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
February 28, 2023 | 9.906M |
November 30, 2022 | 8.133M |
August 31, 2022 | 7.732M |
May 31, 2022 | 7.561M |
February 28, 2022 | 6.368M |
November 30, 2021 | 5.495M |
August 31, 2021 | 3.598M |
May 31, 2021 | 2.977M |
February 28, 2021 | 2.649M |
November 30, 2020 | 1.699M |
August 31, 2020 | 1.758M |
May 31, 2020 | 1.516M |
February 29, 2020 | 6.466M |
November 30, 2019 | 5.686M |
August 31, 2019 | 6.836M |
May 31, 2019 | 5.043M |
February 28, 2019 | 3.806M |
November 30, 2018 | 3.303M |
August 31, 2018 | 0.7071M |
Date | Value |
---|---|
May 31, 2018 | 0.4403M |
February 28, 2018 | 0.5703M |
November 30, 2017 | 0.471M |
August 31, 2017 | 2.494M |
May 31, 2017 | 3.332M |
February 28, 2017 | 2.206M |
November 30, 2016 | 3.512M |
August 31, 2016 | 1.755M |
May 31, 2016 | 1.155M |
February 29, 2016 | 0.9981M |
November 30, 2015 | 0.3873M |
August 31, 2015 | 0.0017M |
May 31, 2015 | 0.0002M |
February 28, 2015 | 0.0001M |
November 30, 2014 | 0.0012M |
August 31, 2014 | 0.0005M |
May 31, 2014 | 0.0005M |
February 28, 2014 | 0.0006M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.516M
Minimum
May 2020
9.906M
Maximum
Feb 2023
5.214M
Average
5.590M
Median
Total Liabilities (Quarterly) Benchmarks
Cantabio Pharmaceuticals Inc | 2.215M |
NVN Liquidation Inc | 82.62M |
Affymax Inc | -- |
Scopus BioPharma Inc | 11.00M |
Statera BioPharma Inc | 22.92M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.465M |
Shareholders Equity (Quarterly) | -6.441M |